Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
65.94
-1.12 (-1.67%)
Dec 15, 2025, 2:00 PM EST - Market open
Structure Therapeutics Employees
Structure Therapeutics had 163 employees as of December 31, 2024. The number of employees increased by 70 or 75.27% compared to the previous year.
Employees
163
Change (1Y)
70
Growth (1Y)
75.27%
Revenue / Employee
n/a
Profits / Employee
-$1,292,546
Market Cap
4.00B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 163 | 70 | 75.27% |
| Dec 31, 2023 | 93 | 25 | 36.76% |
| Dec 31, 2022 | 68 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GPCR News
- 3 days ago - Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional ADSs - GlobeNewsWire
- 5 days ago - Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants - GlobeNewsWire
- 6 days ago - Structure Therapeutics: Phase 2b Puts Aleniglipron In The Oral GLP-1 Top Tier (Rating Upgrade) - Seeking Alpha
- 6 days ago - Why Structure Therapeutics Stock Doubled and Then Some on Monday - The Motley Fool
- 6 days ago - Structure Therapeutics Inc. (GPCR) Discusses Topline Results from ACCESS Program of Oral Small Molecule GLP-1 Receptor Agonist Transcript - Seeking Alpha
- 6 days ago - Structure: Maintaining Strong Buy As Aleniglipron Succeeds In Obesity Study Program - Seeking Alpha
- 6 days ago - Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded Warrants - GlobeNewsWire
- 7 days ago - Crude Oil Falls Over 1%; Structure Therapeutics Shares Jump - Benzinga